842
Participants
Start Date
March 7, 2011
Primary Completion Date
July 21, 2011
Study Completion Date
January 26, 2014
Influenza A (H5N1) Virus monovalent vaccine
All subjects will receive 2 doses administered as an intramuscular (IM) injection.
Saline placebo
All subjects will receive 2 doses administered as an intramuscular (IM) injection.
GSK Investigational Site, Khon Kaen
GSK Investigational Site, Bardstown
GSK Investigational Site, Cleveland
GSK Investigational Site, St Louis
GSK Investigational Site, Newton
GSK Investigational Site, Omaha
GSK Investigational Site, Metairie
GSK Investigational Site, Fort Worth
GSK Investigational Site, San Angelo
GSK Investigational Site, Henderson
GSK Investigational Site, Paramount
GSK Investigational Site, Sacramento
GSK Investigational Site, Coquitlam
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Hamilton
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Sherbrooke
Lead Sponsor
GlaxoSmithKline
INDUSTRY